The 30th Annual Meeting of the Japanese Society for Vaccinology/The 67th Annual Meeting of the Japanese Society of Clinical Virology

*Yuta Kunishima^1,2, Kota Senpuku^1,3, Kotaro Taniguchi^1,3, Toshiro Hirai^1,3,4,5, Yasuo Yoshioka^1,2,3,4,5 (1. Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases, The University of Osaka, 2. The Research Foundation for Microbial Diseases of Osaka University, 3. Laboratory of Nano-design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, The University of Osaka, 4. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 5. Center for Advanced Modalities and DDS, The University of Osaka)

*RASHEDA PERVEEN¹, Seiho Nagafuchi¹, Keiichiro Mine², Hitoe Mori¹, Keizo Anzai³, Hirokazu Takahashi^1,4 (1. Department of Internal Medicine (Division of Hepatology, Diabetes and Endocrinology), Faculty of Medicine, Saga University, 2. Department of Biology, Boston College, USA, 3. Diabetes, Endocrinology and Metabolism Center, Imari Arita Kyoritsu Hospital, 4. Liver Disease Center, Saga University Hospital, Saga University, Japan)

*Shura Yarimizu¹, Takuya Hemmi^1,2,3, Nozomi Abe¹, Yuma Sato¹, Takao Hashiguchi¹ (1. Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, 2. Host Protection Dynamics Team, Center for Infectious Disease Education and Research, The University of Osaka, 3. Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan)

*Kyoko Kohara¹, Jyun-ichiro Takano², Kitab Bouchra¹, Mohammad Kayesh¹, Fumihiko Yasui³, Tomoko Honda³, TUN MYA MYAT⁴, Ryosuke Suzuki⁵, Atsushi Yamanaka⁶, Koji Ishii⁵, Yasuhiro Yasutomi², Kouichi Morita⁴, Michinori Kohara³ (1. Kagoshima University, 2. Primate medical research center, 3. Tokyo Metropolitan Institute, 4. Nagasaki University, 5. NIID, 6. Osaka University)

*Noriko Shimasaki¹, Ryuichi Sugiyama¹, Kayoko Sato², Toru Takenaga^1,3, Hiyori Okura¹, Yusuke Nakai^1,3,4, Hideki Asanuma¹, Eita Sasaki¹, Seiichiro Fujisaki¹, Noriko Kishida¹, Shinji Watanabe¹, Hideki Hasegawa¹, Shigeyuki Itamura¹, Yuichi Harada¹ (1. Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, 2. Department of Respiratory Viruses, National Institute of Infectious Diseases, Japan Institute for Health Security, 3. Department of Diagnostic Testing and Technology Research, National Institute of Infectious Diseases, Japan Institute for Health Security, 4. Department of Bioinformatics and Integrative Omics, National Institute of Infectious Diseases, Japan Institute for Health Security)